Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
In a prospective study conducted in 2020 to 2021, macrolide resistance-associated mutations were found in 41% of pregnant persons in Birmingham, AL, with Mycoplasma genitalium detected. We retrospectively evaluated M. genitalium in 203 pregnant persons participating in a study conducted in 1997 to 2001 in Birmingham and adjacent areas and found a prevalence of 11% (95% confidence interval, 6.9%-15.7%), but no macrolide resistance-associated mutations.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527314 | PMC |
| http://dx.doi.org/10.1097/OLQ.0000000000001843 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Antimicrobial resistance of in Korea for two decades.
Investig Clin Urol
September 2025
Department of Urology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
Purpose: Antimicrobial-resistant (AMR) has become a global concern. To assess AMR patterns in Korea, we analyzed the genetic diversity of the AMR-determining sites (ARDS) in across in 285 samples collected over two decades.
Materials And Methods: -positive samples were collected from various groups: males at one referral center (ORC) from 2014 to 2019 (G1; 43) and from 2020 to 2023 (G2; 54), males at primary care clinics (PCCs) in 2018-2019 (G3; 84), female sex workers at a regional healthcare center in 2004 (G4; 51), and females at PCCs in 2018-2019 (G5; 53).
Generating Whole Bacterial Genomes from Clinical Samples using a Target Enrichment Workflow.
J Vis Exp
August 2025
Institute of Medical Microbiology, University of Zürich;
Obtaining complete genomes of bacterial sexually transmitted infections (STIs) directly from clinical samples is challenging due to the presence of human DNA, microbiota, and very low bacterial pathogen loads. Culture is often not an option, as these species are fastidious, and most samples are taken in transport media that lyse microorganisms, rendering them non-viable for culture. To address these issues, we used a probe panel designed across four species to generate whole-genome sequences of bacterial STIs and performed target enrichment, a two- to three-day hybridization procedure prior to genome sequencing.
View Article and Find Full Text PDFEvaluation of a novel comprehensive sexual health e-testing pathway to inform state-wide roll out in new South wales, Australia.
BMC Infect Dis
August 2025
Sydney Sexual Health Centre, South Eastern Sydney Local Health District, Sydney, NSW, Australia.
Aim: To evaluate the acceptability of MyCheck for asymptomatic sexually transmissible infections (STIs) testing.
Background: Regular testing for STIs in at-risk populations is recommended by Australian guidelines as many STIs are asymptomatic. Consequently, MyCheck was developed to enhance access by combining a telehealth consultation with direct referral to pathology, avoiding the need for in-person clinic visits.
Development and clinical evaluation of a novel SHERLOCK test for .
Microbiol Spectr
August 2025
Department of Clinical Laboratory, Saitama Medical University Hospital, Iruma, Saitama, Japan.
(MG) is a sexually transmitted pathogen associated with urethritis. Nucleic acid amplification tests are the gold standard for its diagnosis but often require specialized equipment, which limits their use in point-of-care testing. This study aimed to develop a rapid, sensitive detection method for MG using a specific high-sensitivity enzymatic reporter unlocking (SHERLOCK) test, which combines isothermal recombinase polymerase amplification and a clustered regularly interspaced short palindromic repeats (CRISPR)-Cas13a reaction.
View Article and Find Full Text PDF